1. www.hhs.gov/partner/bloodsafety
2. Current good manufacturing practice for blood and blood components: (1) quarantine and disposition of units from prior collections from donors with repeatedly reactive screening test for antibody to hepatitis C virus (anti-HCV); (2) supplemental testing, and the notification of consignees and blood recipients of donor test results for anti-HCV.;Guidance for industry;Fed Regist,1998
3. Current good manufacturing practices for blood and blood components: (1) quarantine and disposition of prior collections from donors with repeatedly reactive screening tests for hepatitis C virus (HCV); (2) supplemental testing and notification of consignees and transfusion recipients of donor test results for antibody to HCV (anti-HCV).;Draft guidance for industry;Fed Regist,1999
4. Targeted hepatitis C lookback: Quebec, Canada.;Long;Transfusion,1999
5. Transfusion-acquired hepatitis C: the Danish lookback experience. The Danish HCV [Hepatitis C Virus] Lookback Grou.;Christensen;Transfusion,1999